Detalhe da pesquisa
1.
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.
Mol Ther
; 26(1): 31-44, 2018 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29103912
2.
Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells.
Cancer Res Commun
; 3(1): 66-79, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36968221
3.
The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma.
Cancer Immunol Res
; 9(1): 75-88, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33093217
4.
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies.
Cancer Discov
; 11(5): 1192-1211, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33328215
5.
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid.
JAMA Oncol
; 6(12): 1947-1951, 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33030521
6.
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma.
Sci Transl Med
; 12(533)2020 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32132216
7.
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity.
JCI Insight
; 3(10)2018 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769444